HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuren Ma Selected Research

Percutaneous Coronary Intervention

1/2022Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
1/2017Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuren Ma Research Topics

Disease

15Chronic Obstructive Pulmonary Disease (COPD)
07/2022 - 10/2003
7Pulmonary Emphysema
01/2021 - 05/2005
6Emphysema
12/2018 - 01/2006
4Hemorrhage
01/2022 - 01/2017
4Lung Diseases (Lung Disease)
01/2019 - 01/2006
3Lung Injury
12/2018 - 11/2005
2Disease Progression
04/2019 - 01/2018
2Atrial Fibrillation
01/2017 - 11/2016
2Pneumonia (Pneumonitis)
01/2007 - 11/2005
1Ulcer
01/2022
1Liver Diseases (Liver Disease)
05/2019
1Cystic Fibrosis (Mucoviscidosis)
04/2019
1Cachexia
01/2019
1Inflammation (Inflammations)
01/2019
1Acute Coronary Syndrome
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2017
1Pulmonary Arterial Hypertension
07/2017
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2017
1Stroke (Strokes)
11/2016
1Insulin Resistance
10/2016
1Hyperlipidemias (Hyperlipidemia)
10/2016
1Body Weight (Weight, Body)
10/2016
1Obesity
10/2016
1Hepatocellular Carcinoma (Hepatoma)
06/2015
1Type 2 Diabetes Mellitus (MODY)
07/2014
1Coronary Disease (Coronary Heart Disease)
07/2014
1Bronchitis
10/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2011
1Asthma (Bronchial Asthma)
10/2011
1Hyperoxia
01/2006

Drug/Important Bio-Agent (IBA)

15ElastinIBA
07/2022 - 05/2007
10Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2011
10DesmosineIBA
01/2021 - 05/2007
10IsodesmosineIBA
01/2021 - 05/2007
5Hyaluronic Acid (Hyaluronan)IBA
01/2021 - 05/2005
4SmokeIBA
12/2018 - 05/2005
4Pancreatic Elastase (Elastase)IBA
01/2018 - 01/2006
3Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2013
3Peptides (Polypeptides)IBA
01/2017 - 10/2003
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022 - 01/2017
2Protease Inhibitors (Protease Inhibitor)IBA
01/2021 - 01/2018
2Pharmaceutical PreparationsIBA
01/2021 - 01/2016
2Peptide Hydrolases (Proteases)FDA Link
01/2019 - 01/2018
2EnzymesIBA
06/2015 - 06/2015
2Tobacco Smoke Pollution (Passive Smoking)IBA
10/2011 - 01/2007
2EndotoxinsIBA
01/2007 - 11/2005
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1Capsules (Microcapsules)IBA
01/2022
1Clopidogrel (Plavix)FDA Link
01/2022
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
05/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019
1TicagrelorIBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1CytokinesIBA
01/2019
1Janus KinasesIBA
01/2019
1AerosolsIBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1Glyoxal (Ethanedial)IBA
10/2017
1Advanced Glycation End ProductsIBA
10/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2017
1indium-bleomycinIBA
01/2017
1RivaroxabanIBA
01/2017
1Heparin (Liquaemin)FDA LinkGeneric
01/2017
1AnticoagulantsIBA
01/2017
1bivalirudin (Angiomax)FDA Link
01/2017
1Vitamin KFDA Link
01/2017
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
10/2016
1LipidsIBA
10/2016
1jatrorrhizineIBA
10/2016
1Fibrinogen (Factor I)FDA Link
01/2016
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2016
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
07/2014
1Amino AcidsFDA Link
10/2011
1thiamine triphosphorate (TTP)IBA
02/2009
1Tiotropium Bromide (Spiriva)FDA Link
02/2009
1Oxidants (Oxidizing Agents)IBA
01/2006

Therapy/Procedure

10Therapeutics
01/2022 - 05/2007
2Percutaneous Coronary Intervention
01/2022 - 01/2017
1Contraindications
11/2016